-13

Elena K Joerns1,2, David Karp1, Song Zhang3

  • 1University of Texas Southwestern Medical Center, Department of Internal Medicine, Division of Rheumatic Diseases, Dallas, TX, USA.

Heliyon
|June 17, 2024
PubMed
概括

介素-13 (IL-13) 可能预测间歇性肺病 (ILD) 的稳定性. 较高的IL-13基线水平与较慢的ILD进展相关,表明其作为预后生物标志物的潜力.